Cancer Medicine投稿须知

期刊简介

《Cancer Medicine》是由John Wiley and Sons Ltd出版社于2012年创办的英文国际期刊（ISSN: 2045-7634，E-ISSN: 2045-7634），该期刊长期致力于肿瘤学领域的创新研究，主要研究方向为ONCOLOGY。作为SCIE收录期刊（JCR分区 Q2，中科院 2区），本刊采用OA开放获取模式（OA占比1%），以发表肿瘤学领域等方向的原创性研究为核心（研究类文章占比90.86%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在1215篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Cancer Medicine审稿周期约为 19 Weeks 。该刊近年未被列入国际预警名单，年发文量约1215篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
否是否预警
SCIE 期刊收录
1215 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 2区	ONCOLOGY 肿瘤学 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 3区	ONCOLOGY 肿瘤学 3区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q2	151 / 322	53.3%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q2	141 / 322	56.37%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：5.5

SJR：1.174

SNIP：1.033

学科类别	分区	排名	百分位
大类：Medicine 小类：Radiology, Nuclear Medicine and Imaging	Q1	81 / 333	75%
大类：Medicine 小类：Oncology	Q2	145 / 404	64%
大类：Medicine 小类：Cancer Research	Q3	120 / 230	48%

期刊发文

First-line immunotherapy or angiogenesis inhibitor combined with chemotherapy for advanced non-small cell lung cancer with EGFR exon 20 insertions: Real-world evidence from China
Author: Yang, Guangjian; Yang, Yaning; Liu, Runze; Li, Weihua; Xu, Haiyan; Hao, Xuezhi; Li, Junling; Zhang, Shuyang; Xu, Fei; Lei, Siyu; Wang, Yan

Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 335-344. DOI: 10.1002/cam4.4852
Identification of unique transcriptomic signatures and key genes through RNA sequencing and integrated WGCNA and PPI network analysis in HIV infected lung cancer
Author: Wu, Liwei; Chen, Yongfang; Wan, Laiyi; Wen, Zilu; Liu, Rong; Li, Leilei; Song, Yanzheng; Wang, Lin

Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 949-960. DOI: 10.1002/cam4.4853
eEF1A1 promotes colorectal cancer progression and predicts poor prognosis of patients
Author: Fan, A-hui; Zhao, Xiaojuan; Liu, Hao; Li, Danxiu; Guo, Tongtong; Zhang, Jiehao; Duan, Lili; Cheng, Hao; Nie, Yongzhan; Fan, Daiming; Zhao, Xiaodi; Lu, Yuanyuan

Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 513-524. DOI: 10.1002/cam4.4848
Construction of a prognostic glycolysis-related lncRNA signature for patients with colorectal cancer
Author: Zhong, Xinyang; He, Xuefeng; Wang, Yaxian; Hu, Zijuan; Huang, Huixia; Zhao, Senlin; Zhang, Hong; Wei, Ping; Li, Dawei

Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 930-948. DOI: 10.1002/cam4.4851
Comparison of recurrence patterns in cervical cancer patients with positive lymph nodes versus negative
Author: Ji, Mei; Liu, Yuan; Hu, Yan; Sun, Jing; Zhu, Haiyan

Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 306-314. DOI: 10.1002/cam4.4860
A real-world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non-small cell lung cancer
Author: Zhang, Baihua; Xiao, Haifan; Pu, Xingxiang; Zhou, Chunhua; Yang, Desong; Li, Xu; Wang, Wenxiang; Xiao, Qin

Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 274-286. DOI: 10.1002/cam4.4889
Circulating tumor cells in neuroblastoma: Current status and future perspectives
Author: Yang, Ran; Zheng, Shan; Dong, Rui

Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 7-19. DOI: 10.1002/cam4.4893
An exploratory clinical trial of apatinib combined with intensity-modulated radiation therapy for patients with unresectable hepatocellular carcinoma
Author: Qiu, Hu; Ke, Shaobo; Cai, Gaoke; Wu, Yong; Wang, Jin; Shi, Wei; Chen, Jiamei; Peng, Jin; Yu, Baoping; Chen, Yongshun

Journal: CANCER MEDICINE. 2023; Vol. 12, Issue 1, pp. 213-222. DOI: 10.1002/cam4.4900

Cancer Medicine

癌症医学

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

相关期刊

怎样选择期刊

投稿相关问题

投稿后咨询